![Atmospheric particle-bound polycyclic aromatic hydrocarbons, n-alkanes, hopanes, steranes and trace metals: PM2.5 source identification, individual and cumulative multi-pathway lifetime cancer risk assessment in the urban environment - ScienceDirect Atmospheric particle-bound polycyclic aromatic hydrocarbons, n-alkanes, hopanes, steranes and trace metals: PM2.5 source identification, individual and cumulative multi-pathway lifetime cancer risk assessment in the urban environment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0048969720353638-ga1.jpg)
Atmospheric particle-bound polycyclic aromatic hydrocarbons, n-alkanes, hopanes, steranes and trace metals: PM2.5 source identification, individual and cumulative multi-pathway lifetime cancer risk assessment in the urban environment - ScienceDirect
![A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles - ScienceDirect A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0001868621001366-ga1.jpg)
A state of the art review on the synthesis, antibacterial, antioxidant, antidiabetic and tissue regeneration activities of zinc oxide nanoparticles - ScienceDirect
![Cancers | Free Full-Text | Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL Cancers | Free Full-Text | Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL](https://www.mdpi.com/cancers/cancers-13-01280/article_deploy/html/images/cancers-13-01280-g001.png)
Cancers | Free Full-Text | Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL
![Cancers | Free Full-Text | Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use Cancers | Free Full-Text | Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use](https://www.mdpi.com/cancers/cancers-14-02640/article_deploy/html/images/cancers-14-02640-g001.png)